Abstract During the development of a given drug formulation, the interactions between the drug and excipients need to be carefully studied to ensure that the drug is stable in the formulation. Enzyme‐based drug interaction involving excipients appears to occur predominantly in preclinical studies. The article discusses drug‐drug interaction potential of pharmaceutical excipients, with a focus on solubilizing excipients.